Similar articles

• The action of ergot alkaloids (ergotamine and dihydroergotoxin) on the functional effects of cerebral ischemia in the cat.

  Boismare F, Streichenberger G. Boismare F, et al. Pharmacology. 1974;12(3):152-9. doi: 10.1159/000136533. Pharmacology. 1974. PMID: 4216904 No abstract available.
• The role of cerebral blood flow for the recovery of the brain after prolonged ischemia.

  Hossmann KA, Lechtape-Grüter H, Hossmann V. Hossmann KA, et al. Z Neurol. 1973;204(4):281-99. doi: 10.1007/BF00316009. Z Neurol. 1973. PMID: 4155720 No abstract available.
• Some new vascular and biochemical aspects of the mechanism of action of ergot compounds.

  Berde B. Berde B. Headache. 1972 Jan;11(4):139-47. doi: 10.1111/j.1526-4610.1972.hed1104139.x. Headache. 1972. PMID: 4400045 No abstract available.
• Endocrine profile of ergot alkaloids.

  Můller EE, Panerai AE, Cocchi D, Mantegazza P. Můller EE, et al. Life Sci. 1977 Dec 1;21(11):1545-58. doi: 10.1016/0024-3205(77)90231-4. Life Sci. 1977. PMID: 202827 Review. No abstract available.
• Teratogen update: ergot and ergotamine.

  Raymond GV. Raymond GV. Teratology. 1995 May;51(5):344-7. doi: 10.1002/tera.1420510511. Teratology. 1995. PMID: 7482356 Review.